Literature DB >> 21307200

Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs.

Nathan M Beach1, Sara M Smith, Sheela Ramamoorthy, Xiang-Jin Meng.   

Abstract

A chimeric porcine circovirus (PCV1-2) with the capsid gene of pathogenic PCV2 cloned into the genomic backbone of nonpathogenic PCV1 is attenuated in pigs but elicits protective immunity against PCV2. In this study, short epitope tags were inserted into the C terminus of the capsid protein of the chimeric PCV1-2 vaccine virus, resulting in a tractable marker virus that is infectious both in vitro and in vivo. Pigs experimentally infected with the epitope-tagged PCV1-2 vaccine viruses produced tag-specific antibodies, as well as anti-PCV2 neutralizing antibodies, indicating that the epitope-tagged viruses could potentially serve as a positive-marker modified live-attenuated vaccine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307200      PMCID: PMC3126229          DOI: 10.1128/JVI.02294-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2.

Authors:  Porntippa Lekcharoensuk; Igor Morozov; Prem S Paul; Nattarat Thangthumniyom; Worawidh Wajjawalku; X J Meng
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions.

Authors:  M Fenaux; P G Halbur; G Haqshenas; R Royer; P Thomas; P Nawagitgul; M Gill; T E Toth; X J Meng
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  A very small porcine virus with circular single-stranded DNA.

Authors:  I Tischer; H Gelderblom; W Vettermann; M A Koch
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

4.  Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV.

Authors:  Porntippa Nawagitgul; Perry A Harms; Igor Morozov; Brad J Thacker; Steven D Sorden; Chalermpol Lekcharoensuk; Prem S Paul
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

5.  Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs.

Authors:  M Fenaux; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Studies on epidemiology and pathogenicity of porcine circovirus.

Authors:  I Tischer; W Mields; D Wolff; M Vagt; W Griem
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 7.  PMWS: experimental model and co-infections.

Authors:  G M Allan; F McNeilly; J Ellis; S Krakowka; A Botner; K McCullough; H Nauwynck; S Kennedy; B Meehan; C Charreyre
Journal:  Vet Microbiol       Date:  2004-02-04       Impact factor: 3.293

8.  The essential and nonessential transcription units for viral protein synthesis and DNA replication of porcine circovirus type 2.

Authors:  Andrew K Cheung
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

9.  Transcriptional analysis of porcine circovirus type 2.

Authors:  Andrew K Cheung
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

10.  A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.

Authors:  M Fenaux; T Opriessnig; P G Halbur; F Elvinger; X J Meng
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  7 in total

1.  The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.

Authors:  Yang Zhan; Wanting Yu; Xiong Cai; Xinnuo Lei; Hongyu Lei; Aibing Wang; Yujie Sun; Naidong Wang; Zhibang Deng; Yi Yang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Affinity proteomics to study endogenous protein complexes: pointers, pitfalls, preferences and perspectives.

Authors:  John LaCava; Kelly R Molloy; Martin S Taylor; Michal Domanski; Brian T Chait; Michael P Rout
Journal:  Biotechniques       Date:  2015-03-01       Impact factor: 1.993

3.  Instability in vitro of a PCV2 infectious clone containing an insertion between ORF1 and ORF2.

Authors:  Dipongkor Saha; Jan V Doorsselaere; Hans J Nauwynck
Journal:  Virus Genes       Date:  2011-11-25       Impact factor: 2.332

4.  Highly efficient cellular uptake of a cell-penetrating peptide (CPP) derived from the capsid protein of porcine circovirus type 2.

Authors:  Wanting Yu; Yang Zhan; Boxin Xue; Yanpeng Dong; Yanfeng Wang; Ping Jiang; Aibing Wang; Yujie Sun; Yi Yang
Journal:  J Biol Chem       Date:  2018-08-14       Impact factor: 5.157

5.  Characterization of epitope-tagged foot-and-mouth disease virus.

Authors:  Julian Seago; Terry Jackson; Claudia Doel; Elizabeth Fry; David Stuart; Michiel M Harmsen; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

6.  Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.

Authors:  Xiangyu Liu; Yangkun Liu; Yuanyuan Zhang; Fan Zhang; Enqi Du
Journal:  BMC Vet Res       Date:  2020-02-07       Impact factor: 2.741

7.  Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.

Authors:  Dongliang Wang; Sujiao Zhang; Yawen Zou; Wanting Yu; Yifan Jiang; Yang Zhan; Naidong Wang; Yanpeng Dong; Yi Yang
Journal:  Front Cell Infect Microbiol       Date:  2018-07-09       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.